UBS Group AG - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 42 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$6,000
-70.0%
5,874
-60.7%
0.00%
Q2 2020$20,000
+300.0%
14,951
+272.3%
0.00%
Q1 2020$5,000
+66.7%
4,016
+167.7%
0.00%
Q4 2019$3,000
-40.0%
1,500
-60.6%
0.00%
Q1 2019$5,000
-76.2%
3,806
-42.2%
0.00%
Q4 2018$21,000
-25.0%
6,585
-44.7%
0.00%
Q3 2018$28,000
-6.7%
11,904
+10.9%
0.00%
Q2 2018$30,000
+150.0%
10,731
+328.6%
0.00%
Q1 2018$12,000
+1100.0%
2,504
+2811.6%
0.00%
Q4 2017$1,00086
+21.1%
0.00%
Q3 2017$071
-17.4%
0.00%
Q2 2017$0
-100.0%
86
-54.5%
0.00%
Q1 2017$1,000
-93.3%
189
-84.9%
0.00%
Q4 2016$15,000
-59.5%
1,255
-47.6%
0.00%
Q3 2016$37,000
+54.2%
2,396
+22.8%
0.00%
Q2 2016$24,000
+700.0%
1,951
+443.5%
0.00%
Q1 2016$3,0003590.00%
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q3 2020.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders